Tapson, Victor

Remdesivir for the Treatment of Covid-19 — Final Report

Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 7,267

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease

Waxman, A., Restrepo-Jaramillo, R., Thenappan, T., Ravichandran, A., Engel, P., Bajwa, A., Allen, R., Feldman, J., Argula, R., Smith, P., et al. (2021) · New England Journal of Medicine

Pulmonary Hypertension Research and TreatmentsInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Cited by 666

Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study

Nathan, S. D., Waxman, A., Rajagopal, S., Case, A., Johri, S., DuBrock, H., De La Zerda, D. J., Sahay, S., King, C., Melendres-Groves, L., et al. (2021) · The Lancet Respiratory Medicine

Pulmonary Hypertension Research and TreatmentsInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Cited by 152